Expression and significance of Fractalkine in rat model of acute liver failure
- VernacularTitle:趋化因子Fractalkine在急性肝功能衰竭大鼠模型中的变化及意义
- Author:
Fengling WANG
;
Yongping CHEN
;
Hailong LIN
;
Zhenzhen PAN
;
Minghua ZHENG
;
Hailong MA
;
Yu HUANG
;
Lanman XU
- Publication Type:Journal Article
- Keywords:
Chemotactic factors;
NF-kappaB;
Liver failure,aeute;
Reverse transcriptasepolymerase chain reaction;
Disease models I Animal
- From:
Chinese Journal of Infectious Diseases
2008;26(6):350-353
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the changes of fractalkine (FKN) in rat model of acute liver failure (ALF) and the role of FKN in liver inflammatory injury.Methods SD rats were divided into tWO groups:6 in normal group and 36 in model group.D-galactosamine(D-Gal) was used to induce ALF in model group.The sera and hepatic tissue samples were collected at 12,24,48,72,120 andl68 h.After D-Gal injection.FKN mRNA and nuclear factor(NF)-kB mRNA in hepatic tissue samples were detected by reverse transcription-polymerase chain reaction (RT-PCR).Results The levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) at 12 h were(208.3±43.5)U/L and (375.2±117.3)lJ/L,respectively,which were both significantly higher than those in normal group[(31.8±2.9)U/L and (90.8±3.1)U/L](t=-9.912 and-5.935,respectively,both P<0.01);the levels of ALT and AST peaked at 72 h after D-Gal injection.The levels of FKN mRNA(O.086±0.009)in model group at 12 h were significantly higher than those (O.044±0.009) in normal group(t=-7.999.P<0.01),and peaked at 72 h (O.333±0.033),then decreased obviously at 120 h. The levels of NF-KB mRNA in the liver of normal rats were very little;and the levels in model group were increased gradually over time,then peaked at 72 h (O.583±0.i01,t=-12.607,P<0.01).FKN mRNA and NF0kB mRNA were positively correlated (r=0.760,P<0.01).Conclusion The FKN expression may play all important role in liver inflammatory injury in rat model of acute liver failure, which could provide a new approach for ALF therapy.
